Green Cross Health Interim Report 30 September 2018

2 018
Half Year Report
www.greencrosshealth.co.nz

GREEN CROSS HEALTH
As at 30 September 2018
Our purpose:
Working together
to support healthier
communities.

We are passionately
committed to the
health and wellness of
New Zealand, and to
providing the best support,
care and advice to our
communities.

This is our promise.
Who we are...
The story behind
Green Cross
Health
Since the 12th century,
a green cross has been
used to represent health
professionals and first
took the form of a serpent
wrapped around the jade
hilt of a sword, used by the
Hospitallers of St Lazarus
in Greece. Widely recognised in
Europe and the USA as

identifying a place to find health care and advice,
we are proud to embrace this legacy in our company
name and the icon we use to identify ourselves.
clinical staff including
qualified nurses, occupational
therapists & physiotherapists
specialist
nursing
services
through Total
Care Health
clients
21,400
community
nurses
166
We believe easy access to
good health care is a right
of everyone in New Zealand
community health
support workers
3,500
Green Cross Health
equity pharmacies
91
64
298
community health
362
pharmacies
310
doctors
nurses
350
41
medical centres
MILLION
31.7
home visits
each year
million
3.8
servicing
255,000
patients
prescription
items dispensed
annually
2
work together.
3
do the right thing.
1
care for our community.
4
look after each other.
our values

HALF YEAR REPORT 2018
1
Business summary
02
Consolidated interim statement of comprehensive income
04
Consolidated interim statement of changes in equity
06
Consolidated interim statement of financial position
08
Consolidated interim statement of cash flows
10
Notes to the financial statements
13
Company directory
25
Contents

2
GREEN CROSS HEALTH
Business
summary
For the six months ended 30 September 2018
9
%
increase in group
revenue to $282m
2 .1
%
increase in pharmacy
same store sales
Green Cross Health has experienced strong revenue growth, recording a 9%
increase in Revenue to $282m for the six months to 30 September 2018.
However, Net Profit after Tax attributable to our shareholders was down 7.1%
at $8.1m compared $8.8m for the prior period.
Result Summary
• Revenue of $282m up 9%
• EBITDA at $18.4m down 5.2%
• Operating Profit $14.9m down 9.5%
• Net Profit after Tax attributable to shareholders of $8.1m down 7.1%
• Pharmacy revenue growth of 2.2% but Operating Profit down 3.8%
at $13.9m
• Medical performed strongly with Revenue up 37.5% and Operating Profit
up 32.4% to $2m
• Revenue growth in Community Health up 15.3% but Operating Profit down
$1.1m to $0.3m
• Operating Cash Flow returned to normal level at $8.8m
• Net Debt $44.1m up $5.6m primarily due to investment in new acquisitions
• Interim Dividend consistent with prior period at 3.5 cents per share.
Pharmacy Division
Pharmacy revenues of $170.0m, up 2.2% on the same period last year, were
driven by strong dispensary sales up 4.6% and head office revenues while retail
sales remain consistent with the prior year.
Retail sales were influenced by a record low cold and flu season with the
cough/cold and pain categories down 8.6% year-on-year. Conversely, the
beauty categories saw a 7.2% year-on-year increase.
Same store sales growth was 2.1%, while store Gross Margin was down 2.1%
to 34.8%, given the change in sales mix and increased promotional activity.
With focus on cost control Operating Profit before Interest and Tax was $14.5m,
down $0.6m, resulting in an operating margin of 8.2%.
The pharmacy network continues to grow, to 362 Unichem and Life
Pharmacies, with the addition of 5 Licensees in the period.
Medical Division
Revenue for the Medical division increased 37.5% to $34.3m, with Operating
Profit up by 32.4% to $2.0m, driven by improved operational efficiency and
acquisitions. Operating Margin decreased from 6.1% to 5.8% impacted by new
greenfield and acquired medical centre margins. Same centre revenue growth
was 4.9%.

HALF YEAR REPORT 2018
3
Business summary
8
%
increase in medical
centre patient
numbers to 255,000
32.4
%
increase in medical
operating profit to $2m
• For Medical, network and patient growth through targeted acquisition,
building The Doctors brand profile, improving patient access, and
operational efficiency.
• In Community Health, growing the higher needs client base, working with
funders to ensure sustainable provision of home care services and competing
for government tendered services with sustainable margins.
Green Cross Health remain focused on providing accessible, quality primary
health care through our network of health care experts. Our trusted brands
will continue to offer convenient access to the products and services that our
customers want.
Dividend
The Directors have resolved to pay a fully imputed interim dividend of 3.5 cents
per share to shareholders on the register as at 5pm on 11 December 2018.
The dividend will be paid on 21 December 2018.
Thank you to all our loyal customers and to our staff for their ongoing
commitment to providing the best support, care and advice in almost every
New Zealand community.
For and on behalf of the Board
Peter Merton
Chair
Organic growth and three newly acquired medical centres in the period resulted
in an increase in enrolled patients to 255,000, an increase of 18,480 or 8%
since March 2018 and 16% in the last year. The number of practices
in the equity network is now 41, up 10 from this time last year.
Increasing scale and operational capability in Medical is core to the
Green Cross Health growth strategy.
Community Health Division
The Community Health division continued to deliver revenue growth at $78.1m
up 15.3%. Excluding the increase in revenue from funding for support worker
wages, under the Pay Equity settlement, the revenue increase was 8.2%.
All segments contributed to this growth with the ACC portfolio up 3.5%, nursing
specialists Total Care Health up 5.9% and the DHB portfolio up 10.6%.
Revenue growth did not translate to profit due to the continued shortfall in
funding and an increase in leave liability due to Pay Equity. Discussions continue
between industry representatives and the Ministry of Health and District Health
Boards on this issue.
The Community Health Segment Operating profit before Interest and Tax
was $0.3m, down from $1.4m. Targeting higher clinical needs segments,
exiting unprofitable contracts and operational efficiency will lead to
improved profitability.
Future Focus
The group remains on track as the leading primary health care provider
delivering sustainable care in our communities. Priorities for the coming
period include:
• In pharmacy, a focus on core retail disciplines, growing the franchise network,
expanding e-commerce, utilising the Living Rewards loyalty programme for
digital engagement with customers, and operational efficiency.
255,000 patients

4
GREEN CROSS HEALTH
Consolidated
Interim statement of
comprehensive income
For the six months ended 30 September 2018
NoteSix months ended
30 Sep 2018
(Unaudited)
$’000
Six months ended
30 Sep 2017
(Unaudited)
$’000
Operating revenue 5.1
282,375 258,954
Operating expenditure 5.2
(263,988) (239,568)
Depreciation and amortisation
(3,890) (3,349)
Share of equity accounted net earnings
438457

HALF YEAR REPORT 2018
5
Consolidated interim statement of comprehensive income
Six months ended
30 Sep 2018
(Unaudited)
$’000
Six months ended
30 Sep 2017
(Unaudited)
$’000
Operating profit before interest and tax
14,935 16,494
Interest income
38116
Interest expense
(1,110)(1,179)
Profit before tax
13,863 15,431
Tax expense
(3,788)(4,310)
Profit and total comprehensive income for the period
10,075 11,121
Profit after tax and total comprehensive income for the period attributable to:
Shareholders of the Parent
8,147 8,768
Non-controlling interest
1,928 2,353
Earnings per share:
Basic earnings per share (cents)
5.69 6.25
Diluted earnings per share (cents)
5.68 6.23
The consolidated interim financial statements should be read in conjunction with the accompanying notes

6
GREEN CROSS HEALTH
Consolidated
Interim statement of
changes in equity
For the six months ended 30 September 2018
September 2018
NoteShare
capital
$’000
Retained
earnings
$’000
Non-
controlling
interest
$’000
Total
equity
$’000
As at 1 April 2018
90,609 30,346 7,108 128,063
Profit and total comprehensive income for the period
8,147 1,928 10,075
Transactions with owners, recorded directly in equity
Issue of shares
6
Dividends to shareholders
7 (5,010)(5,010)
Distributions to non-controlling interests
(1,046)(1,046)
Impact of other transactions with non-controlling interests
(243)383140
Share scheme amortisation
1 1
As at 30 September 2018
90,610 33,240 8,373 132,223

HALF YEAR REPORT 2018
7
Consolidated interim statement of changes in equity
September 2017
NoteShare
capital
$’000
Retained
earnings
$’000
Non-
controlling
interest
$’000
Total
equity
$’000
As at 1 April 2017
83,887 23,488 4,855 112,230
Profit and total comprehensive income for the period
8,768 2,353 11,121
Transactions with owners, recorded directly in equity
Issue of shares
6 3,297 3,297
Dividends to shareholders
7(4,883)(4,883)
Distributions to non-controlling interests
(1,251)(1,251)
Impact of other transactions with non-controlling interests
(106)(106)
Share scheme amortisation
1111
As at 30 September 2017
87,195 27,267 5,957120,419
The consolidated interim financial statements should be read in conjunction with the accompanying notes

8
GREEN CROSS HEALTH
Consolidated
Interim statement of
financial position
As at 30 September 2018
NoteAs at
30 Sep 2018
(Unaudited)
$’000
As at
31 Mar 2018
(Audited)
$’000
As at
30 Sep 2017
(Unaudited)
$’000
Current assets
Cash and cash equivalents
9,688 10,754 14,704
Trade and other receivables
25,78323,075 24,582
Contract assets
212,07113,65612,396
Inventories
36,753 34,199 35,316
Total current assets
84,295 81,684 86,998
Non-current assets
Property, plant and equipment
19,927 20,91623,053
Intangible assets
141,781134,948123,659
Contract assets
2793 879498
Deferred tax asset
10,409 10,393 7,832
Equity accounted group investments
6,308 6,264 5,691
Total non-current assets
179,218173,400 160,733
Total assets
263,513 255,084 247,731

HALF YEAR REPORT 2018
9
NoteAs at
30 Sep 2018
(Unaudited)
$’000
As at
31 Mar 2018
(Audited)
$’000
As at
30 Sep 2017
(Unaudited)
$’000
Current liabilities
Payables and accruals
71,22465,125 64,659
Contract liabilities
25,4787,3768,277
Income taxes payable
2524,101 836
Borrowings
10,75816,310 6,337
Total current liabilities
87,71292,912 80,109
Non-current liabilities
Payables and accruals
5521,195 1,120
Borrowings
43,026 32,914 46,083
Total non-current liabilities
43,578 34,109 47,203
Total liabilities
131,290 127,021 127,312
Net assets
133,223 128,063120,419
Equity
Share capital
690,610 90,60987,195
Retained earnings
33,240 30,346 27,267
Total equity attributable to shareholders of the Parent
123,850 120,955114,462
Non-controlling interest
8,373 7,1085,957
Total equity
132,223 128,063 120,419
The consolidated interim financial statements should be read in conjunction with the accompanying notes
Consolidated interim statement of financial position

10
GREEN CROSS HEALTH
Consolidated
Interim statement
of cash flows
For the six months ended 30 September 2018
NoteSix months ended
30 Sep 2018
(Unaudited)
$’000
Six months ended
30 Sep 2017
(Unaudited)
$’000
Cash flows from operating activities
Equity accounted investee dividend received
394 233
Receipts from customers
281,887 255,835
Interest received
38
116
Payments to suppliers and employees
(264,766)(230,480)
Interest paid
(1,109)(1,179)
Income taxes paid
(7,653)(7,208)
Net cash inflow from operating activities
8
8,791 17,317

HALF YEAR REPORT 2018
11
NoteSix months ended
30 Sep 2018
(Unaudited)
$’000
Six months ended
30 Sep 2017
(Unaudited)
$’000
Cash flows from investing activities
Purchases of property, plant, equipment and software intangibles
(5,387)(4,514)
Acquisition of interests in subsidiaries and associates
(3,637)(365)
Proceeds from sale of shares in subsidiary
688 25
Net cash outflow from investing activities
(8,336)(4,854)
Cash flows from financing activities
Proceeds from new borrowings
19,000 51,813
Repayment of borrowings
(14,439)(64,930)
Shares issued for cash
6– –
Dividends paid – shareholders
(5,035)(1,586)
Net distributions to non-controlling interests
(1,046)(1,251)
Net cash outflow from financing activities
(1,520)(15,954)
Net decrease in cash and cash equivalents
(1,066)(3,491)
Cash acquired: business combinations
––
Add opening cash and cash equivalents
10,754 18,195
Closing cash and cash equivalents as per consolidated interim statement of financial position
9,688 14,704
Reconciliation of closing cash and cash equivalents to the balance sheet:
Cash and cash equivalents
9,688 14,704
Closing cash and cash equivalents
9,688 14,704
The consolidated interim financial statements should be read in conjunction with the accompanying notes
Consolidated interim statement of cash flows

12
GREEN CROSS HEALTH

HALF YEAR REPORT 2018
13
Notes to the
financial statements
For the six months ended 30 September 2018
1. Reporting entity
Green Cross Health Limited (the “Parent”) is a New Zealand company
registered under the Companies Act 1993 and listed on the NZX Main Board
(“NZX”). The Parent is an FMC Reporting Entity for the purposes of the
Financial Markets Conduct Act 2013.
The consolidated interim financial statements of Green Cross Health Limited
comprise the Parent, its subsidiaries, and its interest in associates
and joint ventures (together referred to as the “Group”).
2. Basis of preparation of financial
statements
(a) Statement of compliance
These consolidated interim financial statements have been prepared in
accordance with Generally Accepted Accounting Practice in New Zealand
(NZ GAAP), NZ IAS 34 Interim Financial Reporting, and other applicable
Financial Reporting Standards as appropriate for profit oriented entities. These
consolidated interim financial statements do not include all of the information
required for full annual financial statements and should be read in conjunction
with the consolidated financial statements of the Group as at and for the year
ended 31 March 2018.
This is the first set of the Group’s financial statements where NZ IFRS 15
Revenue from Contracts with Customers and NZ IFRS 9 Financial Instruments
have been applied. Changes to significant accounting policies are described in
note 2(c).
The consolidated interim financial statements for the six months ended
30 September 2018 and the comparative information for the six months
ended 30 September 2017 are unaudited.
The financial statements were approved for issue by the Board of Directors on
26 November 2018.

14
GREEN CROSS HEALTH
2. Basis of preparation of financial
statements (continued)
(b) Basis of measurement
The financial statements of the Group are prepared under the
historical cost basis unless otherwise noted within the specific
accounting policies below.
(c) Changes in accounting policies
Other than as disclosed below, the accounting policies
applied by the Group in these consolidated interim financial
statements are the same as those applied by the Group
in its consolidated financial statements for the year ended
31 March 2018. The Group has not applied any standards,
amendments to standards and interpretations that are not
yet effective.
The Group receives funding from customers to reflect
increased costs incurred in the provision of services by the
Community Health division.In prior periods this additional
funding was offset against personnel costs incurred. This
funding is now recognised as revenue rather than an offset
against personnel costs. The September 2017 comparative
figures have been restated to reflect this change, resulting
in an increase in revenue of $4.803m and a corresponding
increase in operating expenses of $4.803m. The overall net
effect on reported September 2017 net profit and operating
cash flows is nil.
The changes in accounting policies are expected to be
reflected in the Group’s consolidated financial statements as
at and for the year ending 31 March 2019.
The Group has initially adopted NZ IFRS 15 Revenue from
Contracts with Customers and NZ IFRS 9 Financial Instruments
from 1 April 2018. There has been no material effect on
the Group’s financial statements from the adoption of
these standards.
NZ IFRS 15 Revenue from Customers
NZ IFRS 15 establishes a comprehensive framework for determining
whether, how much and when revenue is recognised. It replaced
NZ IAS 18 Revenue, NZ IAS 11 Construction Contracts and related
interpretations. The Group has adopted NZ IFRS 15 using the
retrospective effect method (with practical expedients), with the effect of
initially applying this standard recognised at the date of initial application
being 1 April 2018.
All available practical expedients have been utilised where applicable
and the estimated effect on the financial statements of applying the
expedients has been nil other than the restatement described above
and the reclassification of contract assets and contract liabilities in the
Statement of Financial Position.
Current contract assets represent revenue where the service has been
provided but not yet invoiced to the customer. When the customer has
been invoiced, any outstanding balances are included in receivables.
Non current contract assets represent capitalised contract acquisition
costs. Contract liabilities reflect payments received for services that have
not yet been provided and the payments will be recognised as revenue
over time.
Costs directly related to the acquisition of a contract or renewal of an
existing contract are capitalised and amortised over
the life of the contract.
Notes to the financial statements

HALF YEAR REPORT 2018
15
2. Basis of preparation of financial
statements (continued)
(d) Comparatives
Where appropriate comparative information has been reclassified to
conform to the current period’s presentation.
3. Accounting estimates and judgments
In authorising the consolidated interim financial statements for the six
months ended 30 September 2018, the Directors have ensured that the
specific accounting policies necessary for the proper understanding of the
financial statements have been disclosed, and that all accounting policies
adopted are appropriate for the Group’s circumstances and have been
consistently applied throughout the period for all Group entities for the
purposes of preparing the consolidated interim financial statements.
Inherent in the application of certain accounting policies, judgments and
estimates are required. The Directors note that the actual results may differ
from the judgments and estimates made. The significant judgements made
by management in applying the Group’s accounting policies were the same
as those described in the last annual financial statements, except for new
judgements related to the application of NZ IFRS 15 and NZ IFRS 9.
Notes to the financial statements

16
GREEN CROSS HEALTH
September 2018 Note
Pharmacy
services
$’000
Medical
services
$’000
Community
Health
$’000
Corporate
$’000
Total
$’000
Total revenue
169,994 34,302 78,080 – 282,375
Cost of products sold
(99,244)– – – (99,244)
Employee benefit expense
(30,536)(25,399)(74,665)– (130,600)
Lease expense
(7,949)(1,959)(586)– (10,494)
Other expenses
(15,824)(4,778)(1,809)(836) (23,247)
Depreciation and amortisation
(2,633)(506)(751)– (3,890)
Share of equity accounted net earnings
93345 – – 438
Segment Profit
13,901 2,005 269 (836)15,339
Increase in unfunded leave liability due to pay equity legislation 5.2
(404)
Interest income
38
Interest expense
(1,110)
Profit before tax
13,863
Tax expense
(3,788)
Profit after tax
10,075
Non-controlling interest
(1,928)
Net Profit attributable to the shareholders of the parent
8,147
Reportable Segment assets
197,021 38,260 41,392 (13,160)263,513
Reportable Segment liabilities
*Intersegment eliminations
96,26824,949 23,233 (13,160)*131,290
Notes to the financial statements
4. Segment reporting
The Group has three reportable segments: pharmacy services, medical services, community health and a corporate segment.
The Group’s main operations are in the pharmacy industry providing pharmacy services through consolidated stores, equity accounted investments and franchise stores.
The medical services segment includes fully owned and equity accounted medical centres, and support services provided to these medical centres, as well as medical centres outside
the Group. The community health services segment provide services direct to the community to support independent living.

HALF YEAR REPORT 2018
17
4. Segment reporting (continued)
September 2017
Pharmacy
services
$’000
Medical
services
$’000
Community
Health
$’000
Corporate
$’000
Total
$’000
Total revenue
166,306 24,951 67,697 – 258,954
Cost of products sold
(95,839)– – – (95,839)
Employee benefit expense
(30,709)(18,306)(62,937)– (111,952)
Lease expense
(8,218)(1,438)(564)– (10,221)
Other expenses
(14,678)(3,732)(2,309)(837) (21,556)
Depreciation and amortisation
(2,546)(282) (522)–(3,349)
Share of equity accounted net earnings
135 322 – – 457
Segment Profit
14,450 1,515 1,366 (837) 16,494
Interest income
116
Interest expense
(1,179)
Profit before tax
15,431
Tax expense
(4,310)
Profit after tax
11,121
Non-controlling interest
(2,353)
Net profit attributable to the shareholders of the parent
8,768
Reportable segment assets
184,91234,803 40,528 (12,511)247,731
Reportable segment liabilities
*Intersegment eliminations
96,368 20,892 22,564 (12,511)*127,312
Notes to the financial statements

18
5. Operating Performance
5.1 Revenue
The Group’s operations and revenue streams are those described in the last annual financial statements. The Group’s revenue is derived from contracts
with customers, except for retail sales, patient co-payment fees, rent received and other non-contracted services provided to customers and suppliers.
The nature and effect of initially applying NZ IFRS 15 on the Group’s interim financial statements is disclosed in Note 2.
Revenue from contracts with customers
Six months ended
30 Sep 2018
(Unaudited)
$’000
Six months ended
30 Sep 2017
(Unaudited)
$’000
Revenue from contracts with customers
181,789 159,304
Revenue from other sources
100,58699,650
282,375 258,954
Six months ended 30 September 2018
Pharmacy
services
$’000
Medical
Services
$’000
Community
Health
$’000
Total
$’000
Timing of revenue recognition
Transferred at a point in time
66,217 6,45554,92472,672
Transferred over time
15,77415,34423,075109,117
81,99121,79977,999181,789
Disaggregation of Revenue
Reportable segments

HALF YEAR REPORT 2018
19
Notes to the financial statements
Six months ended 30 September 2017
Pharmacy
services
$’000
Medical
Services
$’000
Community
Health
$’000
Total
$’000
Timing of revenue recognition
Transferred at a point in time
63,2184,28447,58167,502
Transferred over time
13,26610,96519,99091,802
76,48515,24867,571159,304
5.2 Operating expenses
Six months ended
30 Sep 2018
(Unaudited)
$’000
Six months ended
30 Sep 2017
(Unaudited)
$’000
Cost of products sold
99,244 95,839
Employee benefit expense
130,600111,952
Lease expense
10,49410,221
Other expenses
23,65121,556
263,988 239,568
Employee benefit expense includes $0.404m cost as a result of the pay equity implementation within the Community Health
business not being fully funded by the Ministry of Health (Sept 2017: nil, March 2018: $1.94m)
5.1 Revenue (continued)

20
GREEN CROSS HEALTH

HALF YEAR REPORT 2018
21
6. Shares on issue
As at
30 Sep 2018
(Unaudited)
’000
As at
31 Mar 2018
(Audited)
’000
As at
30 Sep 2017
(Unaudited)
’000
Shares authorised and on issue
Opening number of shares
143,486 139,835 139,835
Shares issued – fully paid
–3,651 1,578
Shares held as treasury stock
143,486
(333)
143,486
(333)
141,413
(333)
Closing number of shares
143,153 143,153 141,080
Net tangible liabilities per share (cents)
(14.50)(12.68)(8.20)
Net assets per share (cents)
92.3789.4685.36
7. Distribution to owners
On 29 June 2018 Green Cross Health Limited paid a final dividend for the March 2018 year of 3.5 cents per qualifying ordinary share to shareholders,
which was fully imputed to 28%.

22
GREEN CROSS HEALTH
9. Subsequent events
On 26 November 2018 Green Cross Health Limited declared dividends of 3.5 cents per qualifying ordinary share, which will be fully imputed to 28%.
No adjustments are required to these consolidated interim financial statements in respect to this event.
8. Operating cash flows reconciliation
Six months ended
30 Sep 2018
(Unaudited)
$’000
Six months ended
30 Sep 2017
(Unaudited)
$’000
Profit after tax for the period
10,075 11,121
Add/(deduct) non-cash items:
Depreciation & asset write-off
3,890 3,349
Other non-cash items
(703) 28
Add/(deduct) changes in working capital items:
Receivables and accruals
(1,123)(3,116)
Inventory
(2,554)(1,603)
Payables and accruals
(794) 7,538
Net cash inflow from operating activities
8,79117,317

HALF YEAR REPORT 2018
23

24
GREEN CROSS HEALTH

HALF YEAR REPORT 2018
25
Registered office
Green Cross Health Limited
Ground Floor, Building B
602 Great South Road
Ellerslie, Auckland 1051
Telephone: +64 9 571 9080
Board
P M Merton, Chair
J A Bagnall, Non-Executive Director
J B Bolland, Non-Executive Director
P J Williams, Non-Executive Director
A W Edwards, Independent Director
M M Millard, Independent Director
K A Orr, Independent Director
C M Steele, Independent Director
Officers
S J Browning Group CFO
Board Secretary
J H Greenwood BCom, FCA
Green Cross Health Limited
Private Bag 11 906
Ellerslie, Auckland 1542
Auditor
KPMG
KPMG Centre
18 Viaduct Harbour Avenue
Auckland
Bankers
Bank of New Zealand
80 Queen Street
Auckland 1010
Company
directory
As at 30 September 2018
Share registrar
Computershare Investor
Services Limited
Private Bag 92119
Level 2
159 Hurstmere Road
Takapuna
Auckland 0622
Websites
www.greencrosshealth.co.nz
www.access.org.nz
www.lifepharmacy.co.nz
www.livingrewards.co.nz
www.thedoctors.co.nz
www.unichem.co.nz
Managing your
shareholding online:
To change your address, update
your payment instructions and
to view your registered details
including transactions, please visit;
www.investorcentre.com/nz
General enquiries can be
directed to;
enquiry@computershare.co.nz
Private Bag 92119
Auckland 1142
Telephone: + 64 9 488 8777
Facsimile: + 64 9 488 8787
Please assist our registrar by
quoting your CSN or
shareholder number

Green Cross Health Ltd
Ground Floor, Building B
602 Great South Road
Ellerslie, Auckland 1051
Private Bag 11906
Ellerslie, Auckland 1542
www.greencrosshealth.co.nz
03126